Back to Search Start Over

Warburg-like effect is a hallmark of complex I assembly defects.

Authors :
Desquiret-Dumas, Valerie
Leman, Geraldine
Wetterwald, Celine
Chupin, Stephanie
Lebert, Anaïs
Khiati, Salim
Le Mao, Morgane
Geffroy, Guillaume
Kane, Mariame Selma
Chevrollier, Arnaud
Goudenege, David
Gadras, Cedric
Tessier, Lydie
Barth, Magalie
Leruez, Stephanie
Amati-Bonneau, Patrizia
Henrion, Daniel
Bonneau, Dominique
Procaccio, Vincent
Reynier, Pascal
Source :
BBA: Molecular Basis of Disease. Sep2019, Vol. 1865 Issue 9, p2475-2489. 15p.
Publication Year :
2019

Abstract

Due to its pivotal role in NADH oxidation and ATP synthesis, mitochondrial complex I (CI) emerged as a crucial regulator of cellular metabolism. A functional CI relies on the sequential assembly of nuclear- and mtDNA-encoded subunits; however, whether CI assembly status is involved in the metabolic adaptations in CI deficiency still remains largely unknown. Here, we investigated the relationship between CI functions, its structure and the cellular metabolism in 29 patient fibroblasts representative of most CI mitochondrial diseases. Our results show that, contrary to the generally accepted view, a complex I deficiency does not necessarily lead to a glycolytic switch, i.e. the so-called Warburg effect, but that this particular metabolic adaptation is a feature of CI assembly defect. By contrast, a CI functional defect without disassembly induces a higher catabolism to sustain the oxidative metabolism. Mechanistically, we demonstrate that reactive oxygen species overproduction by CI assembly intermediates and subsequent AMPK-dependent Pyruvate Dehydrogenase inactivation are key players of this metabolic reprogramming. Thus, this study provides a two-way-model of metabolic responses to CI deficiencies that are central not only in defining therapeutic strategies for mitochondrial diseases, but also in all pathophysiological conditions involving a CI deficiency. Unlabelled Image • Complex I functional vs structural defects lead to different metabolic adaptations. • Complex I intermediates impair pyruvate oxidation in a ROS/AMPK dependent pathway. • Complex I disassembly drives metabolic reprogramming towards aerobic glycolysis. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09254439
Volume :
1865
Issue :
9
Database :
Academic Search Index
Journal :
BBA: Molecular Basis of Disease
Publication Type :
Academic Journal
Accession number :
137324045
Full Text :
https://doi.org/10.1016/j.bbadis.2019.05.011